Stock-Based Compensation (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2026 |
Dec. 31, 2025 |
| Stock-Based Compensation [Abstract] |
|
|
| Schedule of Stock-Based Compensation Expense |
The following table presents stock-based compensation expense recognized in the accompanying condensed statements of operations: | | | For the Three Months Ended June 30, | | | | | 2026 | | | 2025 | | | | | | | | | | | Research and development | | $ | 27,452 | | | $ | 28,669 | | | General and administrative | | | 33,794 | | | | 20,256 | | | Total | | $ | 61,246 | | | $ | 48,925 | | | | | For the Six Months Ended June 30, | | | | | 2026 | | | 2025 | | | | | | | | | | | Research and development | | $ | 54,904 | | | $ | 69,066 | | | General and administrative | | | 52,521 | | | | 33,632 | | | Total | | $ | 107,425 | | | $ | 102,698 | |
|
The following table summarizes the components of stock-based compensation expense included in the Company’s statements of operations for the years indicated: | | | For the Years Ended December 31, | | | | | 2025 | | | 2024 | | | Research and development | | $ | 678,180 | | | $ | 212,168 | | | General and administrative | | | 675,309 | | | | 57,501 | | | Total | | $ | 1,353,489 | | | $ | 269,669 | |
|
| Schedule of Fair Value of Stock Options Granted/Modified |
|
The Company determined the fair value of stock options granted/modified based upon the following assumptions. | | | For the Years Ended December 31, | | | | | 2025 | | | 2024 | | | Stock price | | $ | 23.10 | | | $ | 21.30 | | | Exercise price | | $ | 23.10 | | | $ | 21.30 | | | Dividend yield | | | 0 | % | | | 0 | % | | Expected volatility | | | 108.8 | % | | | 122.3 – 122.4 | % | | Risk-Free interest rate | | | 3.87 | % | | | 4.29 | % | | Expected life (in years) | | | 5.00 | | | | 6.11 – 6.25 | |
|
| Schedule of Stock Options Outstanding and Exercisable |
|
The following table presents information related to stock options outstanding and exercisable at December 31, 2025: | Options Outstanding | | | Options Exercisable | | | Exercise Price | | | Outstanding Number of Options | | | Weighted Average Remaining Life In Years | | | Exercisable Number of Options | | | $ | 21.30 | | | | 46,577 | | | | 7.37 | | | | 27,578 | | | | 23.10 | | | | 62,840 | | | | 9.50 | | | | 62,840 | | | | 27.80 | | | | 5,745 | | | | 5.39 | | | | 5,745 | | | | 29.00 | | | | 10,136 | | | | 3.44 | | | | 10,136 | | | | 59.20 | | | | 1,690 | | | | 1.09 | | | | 1,690 | | | | | | | | 126,988 | | | | 8.04 | | | | 107,989 | | The following table presents information related to stock options outstanding and exercisable at December 31, 2024: | Options Outstanding | | | Options Exercisable | | | Exercise Price | | | Outstanding Number of Options | | | Weighted Average Remaining Life In Years | | | Exercisable Number of Options | | | $ | 21.30 | | | | 51,710 | | | | 8.27 | | | | 18,531 | | | | 27.80 | | | | 7,435 | | | | 6.33 | | | | 5,576 | | | | 29.00 | | | | 10,136 | | | | 4.44 | | | | 10,136 | | | | 59.20 | | | | 1,690 | | | | 2.09 | | | | 1,690 | | | | | | | | 70,971 | | | | 6.60 | | | | 35,933 | |
|
| Schedule of Warrant Activities for Purchase of Common Stock |
|
The following is a summary of warrant activities for the purchase of Common Stock for the years ended December 31, 2025 and 2024: | | | Number of Warrants | | | Weighted Average Exercise Price | | | Weighted Average Remaining Life In Years | | | Outstanding, January 1, 2024 | | | 33,455 | | | $ | 48.42 | | | | 4.60 | | | Granted | | | — | | | | | | | | | | | Exercised | | | — | | | | | | | | | | | Forfeited | | | — | | | | | | | | | | | Outstanding December 31, 2024 | | | 33,455 | | | $ | 48.42 | | | | 3.60 | | | Granted | | | — | | | | | | | | | | | Exercised | | | — | | | | | | | | | | | Forfeited | | | (6,758 | ) | | | 59.20 | | | | — | | | Outstanding December 31, 2025 | | | 26,697 | | | $ | 45.68 | | | | 3.36 | | | Exercisable, December 31, 2024 | | | 33,455 | | | $ | 48.42 | | | | 3.60 | | | Exercisable, December 31, 2025 | | | 26,697 | | | $ | 45.68 | | | | 3.36 | |
|
| Schedule of Information Related to Warrants to Purchase Common Stock Outstanding and Exercisable |
|
The following table presents information related to warrants to purchase Common Stock outstanding and exercisable at December 31, 2025: | Warrants Outstanding | | | Warrants Exercisable | | | Exercise Price | | | Outstanding Number of Warrants | | | Weighted Average Remaining Life In Years | | | Exercisable Number of Warrants | | | $ | 21.30 | | | | 2,535 | | | | 6.51 | | | | 2,535 | | | | 23.70 | | | | 845 | | | | 4.53 | | | | 845 | | | | 27.80 | | | | 4,224 | | | | 5.50 | | | | 4,224 | | | | 29.00 | | | | 3,379 | | | | 3.00 | | | | 3,379 | | | | 59.20 | | | | 15,714 | | | | 2.29 | | | | 15,714 | | | | | | | | 26,697 | | | | 3.36 | | | | 26,697 | | The following table presents information related to warrants to purchase Common Stock outstanding and exercisable at December 31, 2024: | Warrants Outstanding | | | Warrants Exercisable | | | Exercise Price | | | Outstanding Number of Warrants | | | Weighted Average Remaining Life In Years | | | Exercisable Number of Warrants | | | $ | 21.30 | | | | 2,535 | | | | 7.51 | | | | 2,535 | | | | 23.70 | | | | 845 | | | | 5.52 | | | | 845 | | | | 27.80 | | | | 4,224 | | | | 6.50 | | | | 4,224 | | | | 29.00 | | | | 3,379 | | | | 4.00 | | | | 3,379 | | | | 59.20 | | | | 22,472 | | | | 2.48 | | | | 22,472 | | | | | | | | 33,455 | | | | 3.60 | | | | 33,455 | |
|
| Schedule of Stock Option Activities |
|
The following is a summary of stock option activities for the years ended December 31, 2025 and 2024: | | | Number of Options | | | Weighted Average Exercise Price | | | Weighted Average Grant Date Fair Value | | | Weighted Average Remaining Life In Years | | | Intrinsic Value | | | Outstanding, January 1, 2024 | | | 52,796 | | | $ | 24.92 | | | $ | 19.03 | | | | 7.96 | | | $ | — | | | Granted | | | 18,788 | | | | 21.30 | | | | 18.91 | | | | 10.00 | | | | | | | Exercised | | | — | | | | | | | | | | | | | | | | | | | Forfeited | | | (613 | ) | | | 21.30 | | | | 18.85 | | | | 8.83 | | | | | | | Outstanding, December 31, 2024 | | | 70,971 | | | $ | 23.98 | | | $ | 19.00 | | | | 7.53 | | | $ | — | | | Granted | | | 62,840 | | | | 23.10 | | | | 18.40 | | | | 10.00 | | | | | | | Exercised | | | — | | | | | | | | | | | | | | | | | | | Forfeited | | | (6,823 | ) | | | 22.91 | | | | 19.58 | | | | 7.43 | | | | | | | Outstanding, December 31, 2025 | | | 126,988 | | | $ | 23.60 | | | $ | 18.67 | | | | 7.98 | | | $ | — | | | Exercisable, December 31, 2024 | | | 35,933 | | | $ | 26.26 | | | $ | 19.32 | | | | 6.60 | | | $ | — | | | Exercisable, December 31, 2025 | | | 107,989 | | | $ | 24.01 | | | $ | 18.68 | | | | 8.04 | | | $ | — | |
|